Schedule 13G ownership disclosure

Ventyx Biosciences Inc

Common Stock · CUSIP: 92332V107

Event date: 2024-12-31

Filing-level shares
4,616,536.00
Percent of class
6.5%
  • BANK OF AMERICA CORP /DE/

    Shares: 4,616,536.00 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000070858-25-000131
Form type
SCHEDULE 13G
Filer
BANK OF AMERICA CORP /DE/
CIK
CIK 70858
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub